AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Surge Analysis
/
Propanc Biopharma Inc.
/
2026-06-11
▲ SURGE
Propanc Biopharma Inc.
+80.0%
PPCB
NASDAQ
Healthcare
2026-06-11
2.43
Close
1.35
Prev Close
+80.00%
Change
8324.2x
Vol Ratio
Why It Surged
2026년 5월 14일, Propanc Biopharma(PPCB)는 3분기 주당순이익(EPS)이 전년 동기 -12.50달러에서 개선된 -0.28달러를 기록했다고 발표했다.
·
2026년 5월 14일, Propanc Biopharma(PPCB)는 3분기 주당순이익(EPS)이 전년 동기 -12.50달러에서 개선된 -0.28달러를 기록했다고 발표했다.
Related News
Propanc Biopharma Q3 EPS $(0.28) Up From $(12.50) YoY - Propanc Biopharma (NASDAQ:PPCB)
Benzinga
2026-05-14
Cancer immunotherapy company Purple Biotech keeps its Nasdaq listing
Stocktitan
2026-03-17
New May data will show verekitug effects in nasal polyp patients
Stocktitan
2026-04-17
Protagenic Therapeutics Announces Termination of Chief Financial Officer
Tipranks
2026-04-07
Patent Cliff Risk: How Expiring Protections Threaten Purple Biotech’s Future Exclusivity and Returns
Tipranks
2026-03-20
Technical Analysis
Signals
BB Upper Break
MACD Bullish
Above SMA20
Key Indicators
62.11
RSI (14)
1.73
SMA 20
1.23
Bollinger Lower
2.23
Bollinger Upper
1.73
Bollinger Mid
-0.16
MACD
-0.21
MACD Signal
0.05
MACD Hist
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Propanc Biopharma Inc. Surged +80.0% on 2026-06-11 — Analysis | Alpha Lenz